Gelonghui, March 20 | Affected by the lifting of the share ban, Hongyuan Pharmaceutical (301246.SZ) plummeted by more than 13% at the beginning of the session. The decline temporarily ranked first in the market. The stock price fell below the 20 yuan mark, with a total market value of 7.8 billion yuan. According to news, the company lifted the listing ban on 112 million restricted shares today, making it the company's initial shareholder's restricted shares, accounting for 27.94% of the company's total share capital. After the ban was lifted, the company still has 252 million restricted shares, accounting for 62.88% of the total share capital.